Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Capital Markets

<ul><li>This is our first report on Teradyne, a leading global supplier of automation equipment for the testing of semiconductors, wireless products, data storage and complex electronics systems.</li><li>In comparison to the previous year, industrial automation, wireless test, and system test revenues grew for Teradyne.</li><li>Teradyne is lowering its shipment plan to align with reduced mobility-related test demand, continued supply shortages, and slower industrial automation growth.</li></ul>

This is our first report on Teradyne, a leading global supplier of automation equipment for the testing of semiconductors, wireless products, data storage and complex electronics systems.In comparison to the previous year, industrial automation, wireless test, and system test revenues grew for Teradyne.Teradyne is lowering its shipment plan to align with reduced mobility-related test demand, continued supply shortages, and slower industrial automation growth.

Teradyne Inc: Initiation of Coverage – Business Strategy & Key Drivers

Insight Provider, CrossASEAN Research

Nicolas Van Broekhoven

Insight Provider

CrossASEAN Research

At CrossASEAN Research we strive to produce unbiased and differentiated on the ground insights on companies across South East Asia. Our Research is produced for the most part after face to face meetings and conversations with company management to dig deep into the long term vision and strategy of the companies we cover. We seek to deliver investable and actionable themes on sectors and markets across SE Asia, often in collaboration with other Insight Providers across the region, pooling the vast experience of the analysts within the Smartkarma Ecosystem. We also offer bespoke work and tailor made trips for our clients. 

Insights across South East Asia

Equity Bottom-Up

<ul>
<li>AEM reported stellar 1H22 results beating street estimates as well as far outpacing their own guidance. CHIPS act in USA will benefit company in FY23.</li>
<li>Stock reaction (+6%) muted despite great outlook and management optimism. Despite record results and strong outlook, stock is down YTD. </li>
<li>AEM is cheap trading at only +/-10x FY22 EPS, too low given the growth and consistent margins profile. Fair Value remains 8 SGD.</li>
</ul>


AEM reported stellar 1H22 results beating street estimates as well as far outpacing their own guidance. CHIPS act in USA will benefit company in FY23.
Stock reaction (+6%) muted despite great outlook and management optimism. Despite record results and strong outlook, stock is down YTD. 
AEM is cheap trading at only +/-10x FY22 EPS, too low given the growth and consistent margins profile. Fair Value remains 8 SGD.


AEM: Stellar 1H22; Deeply Undervalued. Fair Value Remains at 8 SGD.

Taiwan Tech Focused Senior Analyst

Patrick Liao

ASE Technology Holding   / Equity Bottom-Up

<ul>
<li>Hope we could be wrong, but the outlook of 1Q22 could be a bit bearish since we believe ASE Holding (ASEH) revenue/GM will reach ~NT$165bn/19.4% and ~NT$150bn/19.5% in 4Q21/1Q22 respectively. </li>
<li>China has massive local efforts on OSAT business because of low entry barrier. In our views, China can exist very well in lower profit margin to compete.</li>
<li>The worldwide OSAT (Outsourced Semiconductor Assembly and Testing) companies of scale are majorly centered in Asia Pacific area.</li>
</ul>


Hope we could be wrong, but the outlook of 1Q22 could be a bit bearish since we believe ASE Holding (ASEH) revenue/GM will reach ~NT$165bn/19.4% and ~NT$150bn/19.5% in 4Q21/1Q22 respectively. 
China has massive local efforts on OSAT business because of low entry barrier. In our views, China can exist very well in lower profit margin to compete.
The worldwide OSAT (Outsourced Semiconductor Assembly and Testing) companies of scale are majorly centered in Asia Pacific area.


ASE Holding (ASX.US, 3711.TT): The Outlook of 1Q22 Could Be a Bit Bearish as Actionable

<a href="https://www.smartkarma.com/entities/aem-holdings-ltd" target="_blank" data-smartkarma-citation="entities:11019:1" rel="noopener">AEM (AEM SP)</a> reported weak results last week but subsequently announced a 103 million SGD investment by Temasek. The Temasek investment comes ahead of an expected strong 2H21 and 2022 but more importantly right ahead of probable new major customer wins. As well documented AEM is highly dependent on <a href="https://www.smartkarma.com/entities/intel-corp" target="_blank" data-smartkarma-citation="entities:16764:1" rel="noopener">Intel Corp (INTC US)</a> for 80% of its revenues and needs new customers to diversify. Management has quietly been forming new relationships and is in various trial phases with some of the largest semiconductor companies other than Intel. During 1Q21's conf call we first heard of management's growing optimism and this was again reiterated in 2Q21.On the 3Q20 call AEM's Chairman Loke Wai San was asked if he would consider a Nasdaq listing. His answer at the time was "once we get to a billion USD market cap we can consider it". The combination of the Temasek investment and the anticipated major new customer wins will likely get us there. In this regard <a href="https://www.straitstimes.com/business/companies-markets/sgx-and-nasdaq-extend-partnership-to-help-firms-access-capital" target="_blank" rel="noopener">please recall</a> that in July 2020 SGX and Nasdaq agreed to make "dual-listings" between both exchanges easier. What better company to kick-off this agreement than AEM?Fair Value increases to 8 SGD (20x P/E on 0.40 SGD FY22 EPS). Recall, AEM already earned 0.35 SGD EPS in 2020, so assuming new customer wins materialize 0.40 SGD is not a stretch.

AEM (AEM SP) reported weak results last week but subsequently announced a 103 million SGD investment by Temasek. The Temasek investment comes ahead of an expected strong 2H21 and 2022 but more importantly right ahead of probable new major customer wins. As well documented AEM is highly dependent on Intel Corp (INTC US) for 80% of its revenues and needs new customers to diversify. Management has quietly been forming new relationships and is in various trial phases with some of the largest semiconductor companies other than Intel. During 1Q21's conf call we first heard of management's growing optimism and this was again reiterated in 2Q21.On the 3Q20 call AEM's Chairman Loke Wai San was asked if he would consider a Nasdaq listing. His answer at the time was "once we get to a billion USD market cap we can consider it". The combination of the Temasek investment and the anticipated major new customer wins will likely get us there. In this regard please recall that in July 2020 SGX and Nasdaq agreed to make "dual-listings" between both exchanges easier. What better company to kick-off this agreement than AEM?Fair Value increases to 8 SGD (20x P/E on 0.40 SGD FY22 EPS). Recall, AEM already earned 0.35 SGD EPS in 2020, so assuming new customer wins materialize 0.40 SGD is not a stretch.

AEM: Temasek Investment + New Customers = Pre-Cursor to Nasdaq Listing? Fair Value to 8 SGD

<a href="https://www.smartkarma.com/entities/aem-holdings-ltd" target="_blank" data-smartkarma-citation="entities:11019:1" rel="noopener">AEM (AEM SP)</a> posted 1Q21 results which were relatively soft YoY. Management noted that 1Q21 was still much stronger than 1Q19 and 1Q20 was an anomaly. AEM also shared annual guidance between 460-520M SGD for 2021. This was the first time management shared guidance for the year. Given AEM's history we believe this guidance is conservative.During the call the CEO and CFO were confident that growth would significantly pick up from 3Q21 as its largest customer <a href="https://www.smartkarma.com/entities/intel-corp" target="_blank" data-smartkarma-citation="entities:16764:1" rel="noopener">Intel Corp (INTC US)</a> ramps up requirement for its latest test handlers. Longer term the company is hopeful to announce multiple new significant customer wins by 2022. This has been a multi-year process which could now bear fruits next year and would be an important catalyst for the company. We remain convinced AEM also becomes an M&amp;A target at some point which provides downside support to the stock.Nothing in 1Q21 results changes the long-term bull thesis on AEM. Fair Value remains unchanged 5 SGD (40% upside).

AEM (AEM SP) posted 1Q21 results which were relatively soft YoY. Management noted that 1Q21 was still much stronger than 1Q19 and 1Q20 was an anomaly. AEM also shared annual guidance between 460-520M SGD for 2021. This was the first time management shared guidance for the year. Given AEM's history we believe this guidance is conservative.During the call the CEO and CFO were confident that growth would significantly pick up from 3Q21 as its largest customer Intel Corp (INTC US) ramps up requirement for its latest test handlers. Longer term the company is hopeful to announce multiple new significant customer wins by 2022. This has been a multi-year process which could now bear fruits next year and would be an important catalyst for the company. We remain convinced AEM also becomes an M&amp;A target at some point which provides downside support to the stock.Nothing in 1Q21 results changes the long-term bull thesis on AEM. Fair Value remains unchanged 5 SGD (40% upside). 

AEM: Temporary Weakness Creates Buying Opportunity Going into New Product Cycle as of 3Q21

United States

Teradyne, Inc. designs, manufactures, sells, and supports semiconductor test products and services on a world wide basis. The Company's test equipment products and services include: semiconductor test systems, military/aerospace test instrumentation and systems, circuit-board test and inspection systems and automotive diagnostic and test systems.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Teradyne Inc (TER US)

Teradyne Inc: Initiation of Coverage – Business Strategy & Key Drivers

This is our first report on Teradyne, a leading global supplier of automation equipment for the testing of semiconductors, wireless products, data...

Baptista Research

AEM: Stellar 1H22; Deeply Undervalued. Fair Value Remains at 8 SGD.

AEM reported a great set of 1H22 results and raised guidance. Long term thesis remains intact as stock trades at 10x FY22 EPS. Fair value remains...

Nicolas Van Broekhoven

ASE Holding (ASX.US, 3711.TT): The Outlook of 1Q22 Could Be a Bit Bearish as Actionable

Hope we could be wrong, but the outlook of 1Q22 could be a bit bearish since we believe ASE Holding (ASEH) revenue/GM will reach ~NT$165bn/19.4%...

Patrick Liao

AEM: Temasek Investment + New Customers = Pre-Cursor to Nasdaq Listing? Fair Value to 8 SGD

AEM remains a top pick as it digests the Temasek investment and gets ready to list on Nasdaq in 2022. Major new customer wins are likely as...

Nicolas Van Broekhoven

AEM: Temporary Weakness Creates Buying Opportunity Going into New Product Cycle as of 3Q21

AEM had a weaker quarter but it is very confident that a new growth cycle will start in 3Q21 well into 2022. New customer wins in 2022 could start...

Nicolas Van Broekhoven

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)